XML 31 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
OPERATING ACTIVITIES    
Net income $ 1,024,213 $ 904,383
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, including amounts charged to cost of goods sold 222,678 201,674
Amortization, including amounts charged to interest expense 335,523 218,508
Provision for credit losses 27,597 9,462
Benefit for deferred income taxes (36,144) (61,725)
Share-based compensation expense 91,232 79,132
LIFO (credit) expense (71,280) 79,320
Turkey highly inflationary impact 40,129 8,441
Loss on remeasurement of equity investment 11,431 0
Other, net 14,158 (6,972)
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Accounts receivable (1,682,145) (861,202)
Inventories (119,023) (1,413,515)
Income taxes receivable (34,255) 142,441
Prepaid expenses and other assets 54,651 56,787
Accounts payable 497,670 2,391,172
Accrued expenses (234,547) (260,297)
Income taxes payable and other liabilities (43,000) (134,338)
Long-term accrued litigation liability (92,174) (13,683)
NET CASH PROVIDED BY OPERATING ACTIVITIES 6,714 1,339,588 Close
INVESTING ACTIVITIES    
Capital expenditures (186,970) (178,581)
Cost of acquired companies, net of cash acquired (2,310) (1,409,681)
Non-customer note receivable (50,000) 0
Cost of equity investments (8,021) (18,414)
Other, net 15,014 6,781
NET CASH USED IN INVESTING ACTIVITIES (232,287) (1,599,895) Close
FINANCING ACTIVITIES    
Senior notes and loan borrowings 634,946 68,133
Senior notes and loan repayments (119,857) (757,695)
Borrowings under revolving and securitization credit facilities 47,936,041 35,784,977
Repayments under revolving and securitization credit facilities (47,978,721) (35,780,516)
Purchases of common stock (436,378) (807,214)
Exercises of stock options 18,629 31,712
Cash dividends on common stock (212,692) (201,479)
Employee tax withholdings related to restricted share vesting (60,086) (67,954)
Other, net (10,381) (3,355)
NET CASH USED IN FINANCING ACTIVITIES (228,499) (1,733,391) Close
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH (13,671) 88,822 Close
DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH (467,743) (1,904,876) Close
Cash, cash equivalents, and restricted cash at beginning of period 2,752,889 3,593,539
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD $ 2,285,146 $ 1,688,663